Rocky, I believe Medicare is still weighing its options with adu* (approval, rejection or limited approval). It will be interesting to see what occurs if Medicare agrees with fda's advisory committee that adu* provides no benefits to ALZ patients and rejects it.
ANAVEX NOW ... RIGHT NOW ... MONO-STYLE ... for LIFE ... and for ALL AGES!!!
News 
Market Data 
Discover 
